Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials
Autore:
Oremus, M; Wolfson, C; Perrault, A; Demers, L; Momoli, F; Moride, Y;
Indirizzi:
SMBD Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQH3T 1E2, Canada SMBD Jewish Gen Hosp Montreal PQ Canada H3T 1E2 ntreal, PQH3T 1E2, Canada McGill Univ, Joint Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada McGill Univ Montreal PQ Canada H3A 2T5 stat, Montreal, PQ H3A 2T5, Canada McGill Univ, Joint Dept Occupat Hlth, Montreal, PQ H3A 2T5, Canada McGill Univ Montreal PQ Canada H3A 2T5 Hlth, Montreal, PQ H3A 2T5, Canada Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada Univ Montreal Montreal PQ Canada H3C 3J7 rm, Montreal, PQ H3C 3J7, Canada
Titolo Testata:
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
fascicolo: 3, volume: 12, anno: 2001,
pagine: 232 - 236
SICI:
1420-8008(200105/06)12:3<232:IROTMJ>2.0.ZU;2-G
Fonte:
ISI
Lingua:
ENG
Soggetto:
RANDOMIZED CONTROLLED TRIALS; GINKGO-BILOBA; EFFICACY; DEMENTIA; SAFETY;
Keywords:
Alzheimer's disease; clinical trial; drug therapy; interrater reliability; Jadad scale; quality scale;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
33
Recensione:
Indirizzi per estratti:
Indirizzo: Wolfson, C SMBD Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada SMBD Jewish Gen Hosp 3755 Cote Ste Catherine Rd Montreal PQ Canada H3T 1E2
Citazione:
M. Oremus et al., "Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials", DEMENT G C, 12(3), 2001, pp. 232-236

Abstract

Drug therapies for Alzheimer's disease (AD) have been evaluated in clinical trials over the past 2 decades. Systematic reviews of AD drug trials can shed more light on the efficacy of pharmaceutical interventions. The modified Jadad scale can be used to assess the quality of trial reports that are candidates for inclusion in these systematic reviews. The interrater reliability of the modified Jadad scale was examined during such a review. Three blinded reviewers rated the quality of 42 AD drug trial reports: the intraclass correlation coefficient was 0.90. The modified Jadad scale appears to be a useful tool for AD research because of the very good interrater reliability. Also, it is composed of items that are well suited to the specific disease characteristics of AD. Further research should focus on the validityof this instrument. Copyright (C) 2001 S. Karger AG, Basel.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/04/20 alle ore 21:27:38